Effect of a 5-HT1A receptor agonist, flesinoxan, on the extracellular noradrenaline level in the hippocampus and on the locomotor activity of rats-Reference-Cited by-同舟云学术

Effect of a 5-HT1A receptor agonist, flesinoxan, on the extracellular noradrenaline level in the hippocampus and on the locomotor activity of rats

Published:2000-03 Issue:2 Volume:858 Page:393-401
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Suwabe Akira,Kubota Masaharu,Niwa Masanobu,Kobayashi Kazuhiko,Kanba Shigenobu

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference55 articles.

1. Hippocampal noradrenaline release in awake, freely moving rats is regulated by alphe-2 adrenoceptors but not by adenosine receptors;Adrian;J. Pharmacol. Exp. Ther.,1997

2. Effect of 5-HT1A receptor agonist on pattern of rat motor activity in relation to effect on forebrain monoamine synthesis;Ahlenius;Pharmacol. Toxicol.,1993

3. Region-selective effects by 8-OH-DPAT on brain dopamine synthesis in vivo;Ahlenius;Neurochem. Int.,1988

4. Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices;Blandina;J. Pharmacol. Exp. Ther.,1991

5. Comparative effects of chronic 8-OH-DPAT, gepirone and ipsapirone treatment on the sensitivity of somatodendritic 5-HT1A autoreceptors;Bohmaker;Neuropharmacology,1993

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 6-Methoxyflavone and Donepezil Behavioral Plus Neurochemical Correlates in Reversing Chronic Ethanol and Withdrawal Induced Cognitive Impairment;Drug Design, Development and Therapy;2022-05

2. Vortioxetine as an analgesic in preclinical inflammatory pain models: Mechanism of action;Fundamental & Clinical Pharmacology;2021-12-09

3. Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update;Therapeutic Advances in Psychopharmacology;2021-01

4. Vortioxetine reduces pain hypersensitivity and associated depression-like behavior in mice with oxaliplatin-induced neuropathy;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2020-12

5. Vortioxetine: a novel antidepressant for the treatment of major depressive disorder;Expert Opinion on Drug Discovery;2018-11-20